Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/376fb9e9-8500-4189-85ff-7030955337ab/

CBL

Control Bionics Limited
Chart
0.08 AUD
Latest Week 2026-06-05
Snapshot 2026-06-07 · 0.0w · Fresh
0.63
OS Score
59.0%
Value
57.0%
Quality
58.0%
Momentum
0/9
F-Score
0.580
QV
Strategy Eligibility
0 of 23 passing
OS Composite
Trending Value
Quality × Value
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
VC2 Cheapest
📐
EBITDA/EV
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
🌱
GARP
🔄
Shareholder Yield
💰
High Yield
🚀
Momentum Leaders
Market Leaders
Tiny Titans
🔍
Small Cap Value
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
Risk-Adj Momentum
V
Value Analysis
Cheapness relative to fundamentals
59.0%ile
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
41.00000000
/100 — 1=cheapest
VC2 (Trending Value)
41.00000000
/100
VC3 (Buyback)
41.00000000
/100
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
57.0%ile
F-Score
0/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
5yr Consist
No
F-Score of 0/9 flags fundamental deterioration — multiple signals are weakening.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
58.0%ile
6M Return
5.3%
12M Return
125.7%
12-1 Mom
94.3%
Risk-Adj
0.93
Vol 252d
101.3%
Vol 60d
242.9%
↑ Expanding
Max DD 12M
-26.7%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 94% is very strong — a clear uptrend. Near-term vol (243%) is expanding vs long-term (101%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.63
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 145 peers
Sector Value %ile
64.4%
Sector Quality %ile
63.0%
Sector Avg OS
45.1%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
VLS Vita Life Sciences Limited 98.0% 93.0% 98.0% 91.0%
SDI SDI Limited 95.0% 86.0% 87.0% 94.0%
TRI TrivarX Limited 94.0% 82.0% 81.0% 82.0%
TRU TruScreen Group Limited 94.0% 82.0% 80.0% 82.0%
VFX VISIONFLEX FPO [VFX] 92.0% 81.0% 79.0% 81.0%
VBS Vectus Biosystems Limited 92.0% 80.0% 79.0% 80.0%
ACW Actinogen Medical Limited 91.0% 79.0% 78.0% 79.0%
AHE Adheris Health Limited 91.0% 79.0% 77.0% 79.0%
Factor Interactions
Volatility Expanding
60-day vol (243%) significantly exceeds 252-day (101%). Near-term risk is elevated.
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
11.1% avg (1 factors)
Momentum
B
73.1% avg (4 factors)
Risk
F
0.0% avg (1 factors)
Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.630—0
Value %ile0.590—0
Quality %ile0.570—0
Momentum %ile0.580—0
F-Score0.000—1
Confidence0.166—1
Volatility1.013—1
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
MomentumPrice trend strength over different horizons
6M Return
5.3%
12M Return
125.7%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
94.3%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.93
Growth & StabilityEarnings trajectory, consistency, and capital allocation
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
0
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
41
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
41
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
41
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity